News | Radiation Therapy | October 02, 2015

One in three Congressional members sign bipartisan letters to CMS expressing concern

ASTRO praises Congress, 2016 Medicare Physician Fee Schedule, MPFS, payment cuts, radiation oncology

October 2, 2015 — The American Society for Radiation Oncology (ASTRO) applauded the members of Congress who signed letters expressing concerns about the recent and newly proposed Medicare cuts to radiation oncology. The 2016 Medicare Physician Fee Schedule (MPFS), issued by the Centers for Medicare and Medicaid Services (CMS) July 8, proposed new cuts to community-based radiation oncology providers that, if finalized, will amount to payment reductions totaling roughly 20 percent to cancer care over the last 6 years. 

In response to the proposal, letters organized by U.S. Senators Richard Burr (R-N.C.) and Debbie Stabenow (D-Mich.) and Reps. Devin Nunes (R-Calif.) and Paul Tonko (D-N.Y.) were sent to CMS Administrator Andy Slavitt on Sept. 30, 2015. The bipartisan letters signed by 167 House and 40 Senate members objected to Medicare’s proposal to cut radiation oncology payments to community-based cancer centers by approximately 5-7 percent for 2016—potentially higher based on a practice’s particular patient mix.

A significant portion of the cuts were due to changes in how CMS accounts for the costs of the use of linear accelerators and associated imaging equipment, both of which are vital to the delivery of safe and effective radiation therapy. Data from ASTRO’s July survey of the almost 1,400 community-based radiation therapy centers in the United States indicates that with cuts of five to 10 percent, nearly 30 percent of practices may have to close their doors, particularly those operating in rural communities.

“By delivering top-notch care close to home, community cancer clinics are an essential part of our healthcare system. We must ensure that these facilities have the tools they need to thrive so that families dealing with a cancer diagnosis don’t lose access to this proven model of care delivery. By asking CMS to reevaluate these flawed cuts that could harm patients with a diagnosis of breast or prostate cancer, we can ensure that community cancer clinics will be open for those in need,” said Rep. Tonko. In their letter, Senators Burr and Stabenow state that they “recognize the valuable role community-based radiation therapy plays in meeting patients’ oncology needs,” and that they are “concerned that the proposed cuts could further jeopardize patient access to this treatment option.”

For more information: www.astro.org


Related Content

News | Artificial Intelligence

May 2, 2024 — Radformation, Inc., a leader in automation solutions for cancer care, announced today that it has acquired ...

Time May 02, 2024
arrow
News | Prostate Cancer

May 2, 2024 — GT Medical Technologies, Inc. (GT MedTech), a medical device company with the mission of improving the ...

Time May 02, 2024
arrow
Feature | Radiology Business | By William T. Thorwarth Jr., MD, FACR

As we witness a mounting backlash against prior authorization in healthcare, we must explore more effective alternatives ...

Time May 02, 2024
arrow
News | Breast Imaging

May 1, 2024 — Hologic, Inc., a global leader in women’s health, today announced that it signed a definitive agreement to ...

Time May 01, 2024
arrow
News | Breast Imaging

May 1, 2024 — After the issuance of updated breast screening recommendations by the U.S. Preventive Services Task Force ...

Time May 01, 2024
arrow
Feature | Information Technology | By Melinda Taschetta-Millane

The Healthcare Information and Management Systems Society (HIMSS) Global Health Conference and Exhibition brought ...

Time May 01, 2024
arrow
News | FDA

April 30, 2024 — International medical imaging IT and Cybersecurity company Sectra’s digital pathology solution together ...

Time April 30, 2024
arrow
Feature | Breast Imaging | By Christine Book

From implementing artificial intelligence effectively, advocating for radiologists, and working tirelessly to expand ...

Time April 29, 2024
arrow
News | FDA

April 29, 2024 — The U.S. Food and Drug Administration (FDA) announced Elekta Instrument AB is recalling Disposable ...

Time April 29, 2024
arrow
News | Information Technology

April 25, 2024 — NewVue Inc., a leader in innovative cloud-native radiology workflow solutions, announced a strategic ...

Time April 25, 2024
arrow
Subscribe Now